Statements in which the resource exists as a subject.Predicate | Object |
---|
rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
1995-11-15
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
X
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1077-1824
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2-3
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11362915-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:11362915-Antiviral Agents,
pubmed-meshheading:11362915-CD4 Lymphocyte Count,
pubmed-meshheading:11362915-Clinical Trials as Topic,
pubmed-meshheading:11362915-Didanosine,
pubmed-meshheading:11362915-Drug Therapy, Combination,
pubmed-meshheading:11362915-Evaluation Studies as Topic,
pubmed-meshheading:11362915-Humans,
pubmed-meshheading:11362915-Treatment Outcome,
pubmed-meshheading:11362915-Zalcitabine,
pubmed-meshheading:11362915-Zidovudine
|
pubmed:year |
1995
|
pubmed:articleTitle |
ACTG 175 and Delta.
|
pubmed:publicationType |
Newspaper Article
|